|4Dec 1, 8:25 PM ET

Cuca Roberto 4

4 · TELA Bio, Inc. · Filed Dec 1, 2021

Insider Transaction Report

Form 4
Period: 2021-11-29
Cuca Roberto
COO and CFO
Transactions
  • Purchase

    Common Stock

    2021-11-29$12.60/sh+423$5,330423 total
  • Purchase

    Common Stock

    2021-11-30$12.43/sh+838$10,4161,261 total
  • Purchase

    Common Stock

    2021-12-01$12.64/sh+1,780$22,4993,041 total
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.41 to $12.74. The Reporting Person undertakes to provide TELA Bio, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.40 to $12.49. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.55 to $12.65. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    tm2134403d1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT